Safir M, Nitzan I, Hanina Y, Safir A, Levinger E, Heller D
Eye (Lond). 2025; .
PMID: 40021781
DOI: 10.1038/s41433-025-03712-6.
Carr S, Pratt R, White F, Watson W
Allergy Asthma Clin Immunol. 2024; 20(Suppl 3):63.
PMID: 39654051
PMC: 11629513.
DOI: 10.1186/s13223-024-00927-2.
Deva M, Netting M, Weidinger J, Brand R, Loh R, Vale S
World Allergy Organ J. 2024; 17(12):100989.
PMID: 39634513
PMC: 11613179.
DOI: 10.1016/j.waojou.2024.100989.
Alradaddi A, Al Twaim A, Abu-Aliat A, Al-Atass K, Alogayell L, Aldayil M
Dermatol Res Pract. 2024; 2022:5636903.
PMID: 39444785
PMC: 11496595.
DOI: 10.1155/2022/5636903.
Emokpae I, Tobia D, Stamm S, Lundy P, Weimer D, Demory Beckler M
Cureus. 2024; 16(7):e64833.
PMID: 39156317
PMC: 11330270.
DOI: 10.7759/cureus.64833.
Taking It Back to Basics: Re-emphasizing the Role of Moisturization in Atopic Dermatitis.
Chovatiya R
J Clin Aesthet Dermatol. 2024; 17(2):30-31.
PMID: 38444427
PMC: 10911262.
Sensory neurons promote immune homeostasis in the lung.
Tamari M, Del Bel K, Ver Heul A, Zamidar L, Orimo K, Hoshi M
Cell. 2023; 187(1):44-61.e17.
PMID: 38134932
PMC: 10811756.
DOI: 10.1016/j.cell.2023.11.027.
Patient education in atopic dermatitis: a scoping review.
Wilken B, Zaman M, Asai Y
Allergy Asthma Clin Immunol. 2023; 19(1):89.
PMID: 37833754
PMC: 10576377.
DOI: 10.1186/s13223-023-00844-w.
Vegan Diet in Dermatology: A Review.
Lee H, Sim N, Fotouhi A, Daveluy S
J Clin Med. 2023; 12(18).
PMID: 37762741
PMC: 10531971.
DOI: 10.3390/jcm12185800.
A concept for integrated care pathways for atopic dermatitis-A GA LEN ADCARE initiative.
Zuberbier T, Abdul Latiff A, Aggelidis X, Augustin M, Balan R, Bangert C
Clin Transl Allergy. 2023; 13(9):e12299.
PMID: 37746794
PMC: 10500634.
DOI: 10.1002/clt2.12299.
Prevalence of Asthma, Allergic Rhinitis, and Atopic Dermatitis and Their Association With Oral Health in Saudi Arabia.
Alsulami S, Aldoboke A, Nooh R, Kalifih O, Khan S, Marglani O
Cureus. 2023; 15(4):e38061.
PMID: 37234145
PMC: 10208278.
DOI: 10.7759/cureus.38061.
The Anti-Atopic Dermatitis Effects of Essential Oil Are Involved in the Inhibition of the NLRP3 Inflammasome in DNCB-Challenged Atopic Dermatitis BALB/c Mice.
Kim S, Sapkota A, Bae Y, Choi S, Bae H, Kim H
Int J Mol Sci. 2023; 24(9).
PMID: 37175425
PMC: 10177797.
DOI: 10.3390/ijms24097720.
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.
Zuberbier T, Beck L, Bedbrook A, de Bruin-Weller M, Bousquet J, Cork M
Clin Transl Allergy. 2023; 13(3):e12236.
PMID: 36973955
PMC: 10040953.
DOI: 10.1002/clt2.12236.
Atopic Dermatitis and Water: Is There an Optimum Water Intake Level for Improving Atopic Skin?.
Douladiris N, Vakirlis E, Vassilopoulou E
Children (Basel). 2023; 10(2).
PMID: 36832402
PMC: 9954916.
DOI: 10.3390/children10020273.
p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice.
Lee J, Son S, Kim N, Im D
Biomol Ther (Seoul). 2022; 30(6):501-509.
PMID: 35788499
PMC: 9622309.
DOI: 10.4062/biomolther.2022.024.
The effect of probiotics on the clinical status of adult patients with atopic dermatitis: a systematic review.
Sodre C, Vieira M, Estefan J, Moraes C, Cavalcante F, Dos Santos K
Eur J Med Res. 2022; 27(1):94.
PMID: 35701836
PMC: 9199243.
DOI: 10.1186/s40001-022-00713-z.
1-Iodohexadecane Alleviates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice: Possible Involvements of the Skin Barrier and Mast Cell SNARE Proteins.
Kim D, Won K, Hwang D, Kim N, Kim B, Lee H
Molecules. 2022; 27(5).
PMID: 35268661
PMC: 8911872.
DOI: 10.3390/molecules27051560.
The Skin and Nose Microbiome and Its Association with Filaggrin Gene Mutations in Pediatric Atopic Dermatitis.
van Mierlo M, Pardo L, Fieten K, van den Broek T, Schuren F, van Geel M
Dermatology. 2022; 238(5):928-938.
PMID: 35042220
PMC: 9501786.
DOI: 10.1159/000520978.
Salvianolic Acid A Suppresses DNCB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice.
Jeon W, Lee J, Lee J, Son S, Okajima F, Chung K
Evid Based Complement Alternat Med. 2021; 2021:7902592.
PMID: 34691223
PMC: 8531767.
DOI: 10.1155/2021/7902592.
Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response.
Lee Y, Kim M, Nahm D
Allergy Asthma Immunol Res. 2021; 13(5):733-745.
PMID: 34486258
PMC: 8419649.
DOI: 10.4168/aair.2021.13.5.733.